Company Snapshot
- Ticker
- BSX
- Name
- BSX
- Sector
- None
- Currency
- 0
- Relative Volume
- None
- Market Cap
- 137353590000.000000
- Volume
- 9,382,521
- Avg Volume (3M)
- 8,798,109
BSX
BSX
Last update recent
92.70
+0.17
(+0.18%)
Market Cap
137353590000.000000
Dividend Yield
0.00%
1Y Return
None%
Beta
None
Price & Moving Averages
Interactive chart with SMA overlays and intraday breadth.
Profitability
- Revenue
- 19350000000.000000
- EPS
- 1.89
- Dividend / Share
- None
- Total Dividends
- $0.00
- Dividend Yield
- 0.0%
- Net Income
- 2788000000.000000
- Net Margin
- 14.41%
- Payout Ratio
- 0.0%
- Qtly Growth YoY
- None
Valuation & Quality
- P/E
- 49.27
- Forward P/E
- None
- P/S
- 7.10
- P/B
- 0.00
- Beta
- None
- Debt / Equity
- 0.00
- Current Ratio
- 0.00
- Return on Equity
- 0.00%
- Return on Assets
- 0.00%
Technicals & Returns
- Distance vs 200 DMA
- -8.47%
- 200 DMA
- 101.28
- Distance vs 50 DMA
- -6.31%
- 50 DMA
- 98.94
- Return 1Y
- None%
- Return YTD
- None%
- Beta (Trailing)
- None
- Relative Volume
- None
Factor Lens
Plot valuation, momentum, or volume trends.
Seasonal Performance
Company Overview
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides Read more
- Name
- BSX
- Industry
- Medical - Devices
- CEO
- Mr. Michael F. Mahoney
- Employees
- 48,000
- IPO Date
- 1992-05-19
- Phone
- 508 683 4000
- Address
- None
- Website
- https://www.bostonscientific.com
Dividend Yield
0.00%
TTM Distributions
$0.00
Latest News
Curated headlines from premium sources.
4 Medical Device Stocks to Buy for Healthy Returns in 2026
ISRG, PODD, BSX and IDXX lead medtech innovation with AI, robotics and diagnostics for growth in 2026.
Boston Scientific Corporation $BSX Shares Sold by Ameriprise Financial Inc.
Ameriprise Financial Inc. lessened its stake in shares of Boston Scientific Corporation (NYSE: BSX) by 0.8% during the second quarter, according to the company…
Boston Scientific Sustains Momentum in the PFA Market: What's Next?
BSX builds momentum in PFA as FARAPULSE posts strong growth, and new trial results and expanded FDA labeling boost its AF treatment push.
PAHC vs. BSX: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of thes…
Bank of Nova Scotia Raises Position in Boston Scientific Corporation $BSX
Bank of Nova Scotia boosted its holdings in shares of Boston Scientific Corporation (NYSE: BSX) by 106.4% in the undefined quarter, according to its most recen…
Cerity Partners LLC Boosts Stock Holdings in Boston Scientific Corporation $BSX
Cerity Partners LLC lifted its position in Boston Scientific Corporation (NYSE: BSX) by 0.8% in the undefined quarter, according to the company in its most rec…